What is it about?

Cardiovascular diseases (CVD) are one of the main causes of mortality in the world. The development of these diseases has a specific factor—alteration in blood platelet activation.

Featured Image

Why is it important?

It has been shown that phenolic compounds have antiplatelet aggregation abilities and a positive impact in the management of CVD, exerting prominent antioxidant, anti-inflammatory, antitumor, cardioprotective, antihyperglycemic, and antimicrobial effects.

Perspectives

Thus, despite the current advances, further studies are needed to confirm the cardioprotective potential of phenolic compounds towards their use alone or in combination with conventional drugs for effective therapeutic interventions.

habilitated doctor, chemist Monica BUTNARIU
Life Sciences University "King Michael I" from Timisoara, 300645, Calea Aradului 119, Timis, Romania

Read the Original

This page is a summary of: Phenolic Bioactives as Antiplatelet Aggregation Factors: The Pivotal Ingredients in Maintaining Cardiovascular Health, Oxidative Medicine and Cellular Longevity, August 2021, Hindawi Publishing Corporation, DOI: 10.1155/2021/2195902.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page